Lung cancer is the primary cause of cancer deaths and continues to be a significant global health problem. However, remarkable progress is underway in both the prevention and treatment of lung cancer. Lung cancer therapy has now emerged as a role model for tailored cancer medicine, with several significant breakthroughs.
In this issue of the Annals of Translational Medicine, outleading authors have introduced another valued educational source with the newest advances in not small cell lung cancer to keep busy practitioners, scientists, and others interested in lung cancer up-to-date. In this context, the different articles are meant not to be an all-encompassing review, but to cover the highlights along with the necessary references for further reading.